Glucotrack (GCTK) Capital Expenditures Growth (3y) (2013 - 2025)
Glucotrack (GCTK) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -21.70% |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - | 105.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105.41% |
| Dec 31, 2022 | -105.88% |
| Dec 31, 2021 | 28.94% |
| Sep 30, 2020 | 28.48% |
| Mar 31, 2020 | 116.56% |
| Sep 30, 2019 | -24.07% |
| Jun 30, 2019 | -45.99% |
| Mar 31, 2019 | -35.67% |
| Sep 30, 2018 | -72.41% |
| Jun 30, 2018 | -47.52% |
| Mar 31, 2018 | -57.47% |
| Sep 30, 2017 | 60.04% |
| Jun 30, 2017 | -55.81% |
| Mar 31, 2017 | -44.95% |
| Sep 30, 2016 | 17.46% |
| Jun 30, 2016 | -12.22% |
| Mar 31, 2016 | 212.36% |
| Sep 30, 2015 | 180.03% |
| Jun 30, 2015 | 54.37% |
| Mar 31, 2015 | 93.49% |